FinTrust Capital Advisors’s Pacific Biosciences PACB Stock Holding History

FinTrust Capital Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$242	Hold	142	–	–	﹤0.01%	1335
2024 Q2	$195	Hold	142	–	–	﹤0.01%	1335
2024 Q1	$533	Hold	142	–	–	﹤0.01%	1207
2023 Q4	$1.39K	Hold	142	–	–	﹤0.01%	1111
2023 Q3	$1.19K	Hold	142	–	–	﹤0.01%	1089
2023 Q2	$1.16K	Hold	142	–	–	﹤0.01%	1090
2023 Q1	$1.16K	Hold	142	–	–	﹤0.01%	1083
2022 Q4	$1.16K	Hold	142	–	–	﹤0.01%	1080
2022 Q3	$1K	Hold	142	–	–	﹤0.01%	1183
2022 Q2	$1K	Hold	142	–	–	﹤0.01%	1179
2022 Q1	$1K	Hold	142	–	–	﹤0.01%	1183
2021 Q4	$3K	Hold	142	–	–	﹤0.01%	1079
2021 Q3	$4K	Hold	142	–	–	﹤0.01%	1051
2021 Q2	$5K	Hold	142	–	–	﹤0.01%	1049
2021 Q1	$5K	Buy	+142	New	+$4.97K	﹤0.01%	1023

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FinTrust Capital Advisors's PACB Position: Q3 2024 in Review

FinTrust Capital Advisors held its Pacific Biosciences (PACB) position steady in Q3 2024 at 142 shares worth $242. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

FinTrust Capital Advisors first reported a position in PACB in Q1 2021 and has held it in 15 quarters since. The position peaked at $5K in Q2 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

FinTrust Capital Advisors held 142 shares of Pacific Biosciences worth $242 as of Q3 2024.
FinTrust Capital Advisors left its Pacific Biosciences share count unchanged in Q3 2024.
Pacific Biosciences made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1335 holding.
FinTrust Capital Advisors first reported a position in Pacific Biosciences in Q1 2021 and has held it in 15 quarters since.
FinTrust Capital Advisors's Pacific Biosciences position peaked at $5K in Q2 2021.
226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.